An Ex Vivo Chicken Primary Bursal-cell Culture Model to Study Infectious Bursal Disease Virus Pathogenesis
October 4th, 2018
11.2K views
Here we describe the isolation of chicken primary bursal cells from the bursa of Fabricius, the culture and infection of the cells with infectious bursal disease virus, and the quantification of viral replication.
Overview
This article describes the isolation and culture of chicken primary bursal cells, their infection with infectious bursal disease virus (IBDV), and the quantification of viral replication. The method provides insights into the interaction of immunosuppressive viruses with B cells and supports the three Rs in animal research.
Key Study Components
Area of Science
- Avian virology
- Cell culture techniques
- Viral pathogenesis
Background
- Isolation of primary bursal cells is crucial for studying IBDV.
- Immortalized cell lines may not accurately represent in vivo conditions.
- This method reduces the need for animal use in research.
- Understanding B cell responses to IBDV is vital for vaccine development.
Purpose of Study
- To isolate and culture chicken primary bursal cells.
- To investigate the replication of IBDV in these cells.
- To explore the effects of soluble chicken CD40 ligand on cell viability and proliferation.
Methods Used
- Isolation of bursal cells using collagenase digestion.
- Centrifugation and density gradient separation of cells.
- Infection of cultured cells with IBDV strains.
- Quantification of viral RNA using RT-qPCR.
Main Results
- Cells cultured with CD40 ligand increased from 902,000 to 3.63 million per milliliter.
- IBDV replication was confirmed with significant RNA expression at 48 hours post-infection.
- Cell viability improved in the presence of CD40 ligand.
- Insights gained can inform future studies on viral pathogenesis.
Conclusions
- This method allows for the study of IBDV without infecting live birds.
- It supports the three Rs in animal research.
- Further research can explore responses to other viral infections.
Frequently Asked Questions
What is the significance of isolating chicken primary bursal cells?
Isolating these cells allows researchers to study the immune response to viruses like IBDV in a more relevant biological context.
How does the presence of CD40 ligand affect cell viability?
CD40 ligand significantly improves cell viability and proliferation in cultured primary bursal cells.
What are the implications of this research for animal welfare?
The method reduces the number of birds needed for research, aligning with ethical standards for animal use.
Can this method be applied to other viruses?
Yes, the technique can also be applied to study other viruses like ALV and REV.
What are the next steps in this research?
Future studies will investigate the response of these cells to various viral infections and further explore viral pathogenesis.
Executive Industry Relevance
Ex vivo chicken primary bursal-cell culture enables mechanistic interrogation of immunosuppressive viral pathogenesis in a disease-relevant system, supporting predictive confidence in early discovery. This model reduces reliance on in vivo avian studies, aligning with ethical mandates and improving translational continuity for avian vaccine and antiviral R&D. The approach facilitates robust target validation and functional de-risking for pipeline advancement in poultry health portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct study of B cell-virus interactions in a physiologically relevant primary cell context.
- Supports functional target validation for immunosuppressive viral mechanisms.
- Facilitates mechanistic de-risking by distinguishing responses to attenuated versus virulent IBDV strains.
- Improves predictive confidence for downstream intervention strategies.
Screening & Assay Development
- Provides a validated ex vivo system for quantitative viral replication assays using RT-qPCR.
- Enables reproducible measurement of cell viability and proliferation in response to viral challenge and CD40 ligand stimulation.
- Supports assay standardization for comparative evaluation of viral strains and candidate antivirals.
- Prepares a scalable platform for screening additional avian viruses.
Translational & Preclinical Research
- Aligns with disease-relevant avian immunology, enhancing translational biomarker discovery.
- Reduces animal use, supporting ethical and regulatory expectations for preclinical research.
- Enables continuity from in vitro discovery to in vivo validation with reduced biological risk.
- Provides mechanistic insights into immunosuppression relevant to vaccine efficacy studies.
Pipeline & Workflow Integration
This ex vivo model bridges early discovery and preclinical validation by enabling hypothesis-driven studies of viral pathogenesis and immune modulation in primary avian B cells.
- Discovery Biology: Supports null hypothesis testing of viral effects on B cell viability and replication.
- Screening: Delivers quantitative, reproducible outputs for viral load and cell health metrics.
- Analytics: Employs RT-qPCR and imaging to compare strain-specific replication and cellular responses.
- Translational Research: Facilitates alignment with in vivo disease models and biomarker strategies.
- Enterprise Reuse: Adaptable to other avian viruses and species, expanding platform utility across R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in avian viral pathogenesis.
- Operational Value: Standardizes primary cell workflows and enhances reproducibility across studies.
- Strategic Value: Enables risk-adjusted go/no-go decisions and capital-efficient portfolio progression.
- Portfolio Impact: Supports ethical, scalable, and translationally relevant research for poultry health innovation.
Implementation Considerations
- Requires expertise in primary avian cell isolation and culture techniques.
- Demands access to biosafety infrastructure and quantitative molecular assays (e.g., RT-qPCR).
- Necessitates cross-team standardization for cell viability and viral quantification protocols.
- Adaptable to other avian species and viruses with protocol optimization.
- Dependent on availability of specific reagents such as chicken CD40 ligand and validated viral strains.
Biopharma FAQs
Why is null hypothesis testing critical for IBDV target validation?
Null hypothesis testing using primary bursal cells enables rigorous evaluation of whether observed changes in cell viability or viral replication are attributable to specific IBDV strains or interventions. This approach strengthens target validation by distinguishing true biological effects from background variability, supporting confident advancement decisions.
How does independent variable isolation in bursal-cell infection studies fit the discovery pipeline?
Isolating variables such as viral strain or CD40 ligand exposure allows precise attribution of cellular responses, facilitating mechanistic de-risking early in the discovery pipeline. This clarity supports robust hypothesis testing and informs downstream assay development and screening strategies.
What do quantitative RT-qPCR measurements of IBDV VP4 enable in R&D?
Quantitative RT-qPCR of VP4 provides sensitive, reproducible readouts of viral replication kinetics, enabling direct comparison of strain virulence and intervention efficacy. These measurements underpin data-driven decisions for candidate prioritization and mechanistic studies.
Why do replication requirements in ex vivo bursal-cell assays matter for cross-functional teams?
Replication ensures that observed effects on cell viability and viral load are robust and reproducible, facilitating cross-functional collaboration between discovery, screening, and translational teams. Reliable replication supports standardized data interpretation and portfolio-wide confidence.
What statistical analysis capabilities are required before implementing viral quantification workflows?
Implementation requires statistical tools to analyze RT-qPCR data, assess significance of differences between conditions, and validate assay reproducibility. These capabilities are essential for ensuring data integrity and supporting go/no-go decisions in early-stage R&D.
Chapters in this video
0:04
Title
0:45
Isolation of Chicken Primary Bursal Cells
2:59
Culture of Chicken Primary Bursal Cells
3:51
Infection of Chicken Primary Bursal Cells with IBDV and Quantification of IBDV Replication
5:02
Results: Analysis of Chicken Primary Bursal Cell Culture and Infection with Infectious Bursal Disease Virus
6:41
Conclusion
